| Literature DB >> 35646178 |
Shaimaa Abdulhussein Shlash1, Zubaida Falih Alzubaidi1, Huda Ali Saleh1.
Abstract
Cytokine response to Ancylostoma duodenale (A. duodenale) infection was measured after starting treatments with piperazine. This study aims to determine the impact of cytokine production after infection with A. duodenale before and after treatment with piperazine. Blood and stool samples of 50 patients with A. duodenale infection and 28 healthy individuals (control) were collected. In this study, IFNγ, IL-5, IL-12, and IL-13 in serum (using ELISA-based methods) were measured. Stool samples were examined using the Kato-Katz technique to detect A. duodenale parasites. Blood and stool samples were analyzed 14 days after starting piperazine treatment for A. duodenale infection. The medium concentration of IFNγ, IL-5, IL-12, and IL-13 in the serum samples with A. duodenale infection is higher than that of the control group. IFNγ, IL-5, IL-12, and IL-13 levels were significantly higher in the infected individuals (10.5±7.4 pg/ml, 14.6±5.1 pg/ml, 8.5±3.2 pg/ml and 13.6±7.5 pg/ml respectively) than the control group (4.7±2.4 pg/ml, 7.8±4.06 pg/ml, 6.3±3.4 pg/ml and 3.5±2.7 pg/ml respectively). Also, piperazine treatment can significantly reduce cytokines levels (IFN-γ: P=0.043, IL-5: P=0.02, and IL-12, p=0.001). This study shows that piperazine treatment can reduce cytokines profiles in patients with A. duodenale infection. ©2022 JOURNAL of MEDICINE and LIFE.Entities:
Keywords: Ancylostoma duodenale; cytokines; piperazine treatment
Mesh:
Substances:
Year: 2022 PMID: 35646178 PMCID: PMC9126450 DOI: 10.25122/jml-2021-0383
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Comparison of cytokines levels (mean±SD) in patients and the control group.
|
|
|
|
|
|
|---|---|---|---|---|
|
| 4.7±2.4 | 10.5±7.4 | 5.3 | 0.0 |
|
| 7.8±4.06 | 14.6±5.1 | 1.6 | 0.05 |
|
| 6.3±3.4 | 8.5±3.2 | 0.2 | 0.35 |
|
| 3.5±2.7 | 13.6±7.5 | 3.1 | 0.051 |
Effects of piperazine on cytokines levels (mean±SD) in patients with A. duodenale.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
|
| 0.43±0.18 | −0.12±0.31 | −0.77 | −1.45, −0.05 | 0.043 |
|
| −0.85±0.14 | −1.55±0.21 | −0.89 | −1.59, −0.21 | 0.02 |
|
| 1.34±0.15 | −0.83±0.31 | −2.86 | −3.57, −2.23 | 0.001 |
|
| 3.77±0.08 | 3.89±0.09 | −0.09 | −0.20, 0.06 | 0.21 |
*β – Effects of piperazine on cytokines levels (pg/mL) after 14 days of treatment; CI – Change bootstrapped 95% confidence interval in an immune response.
Figure 1.Mean concentration of cytokines levels in patients with A. duodenale and control group.
Figure 2.Mean concentration of cytokines levels in patients with A. duodenale and control group.